View all newsletters
Receive our newsletter – data, insights and analysis delivered to you
  1. Comment
June 20, 2018updated 29 Jun 2018 4:16pm

Thailand: from medical tourism to contract manufacturing

Thailand hopes to use its strength in medical tourism to grow its pharmaceutical sector, claimed industry experts at the Thailand Board of Investment & TCELS Presents: Life Innovation - Business Opportunities in Research & Innovation in Thailand panel at the BIO convention in Boston, MA on Monday, June 4th.

By GlobalData Healthcare

Thailand hopes to use its strength in medical tourism to grow its pharmaceutical sector, claimed industry experts at the Thailand Board of Investment & TCELS Presents: Life Innovation – Business Opportunities in Research & Innovation in Thailand panel at the BIO convention in Boston, MA on Monday, June 4th. The strength of the medical tourism industry grew out of Thailand’s strong leisure tourism industry and relatively well-developed hospital system, when compared to other Association of Southeast Asian Nations (ASEAN) countries (with the exception of Singapore), experts said.

Panelists Nares Damrongchai, CEO of the Thailand Center of Excellence for Life Sciences (TCELS; Bangkok, Thailand), and Sansanalak Rachdawong, Director of Thailand’s National Biopharmaceutical Facility (NBF; Bangkok, Thailand), spoke about the development of Thailand’s innovation economy, or “Thailand 4.0.” The panel looked at how the government of Thailand was actively recruiting foreign investment and matching it with government funding.

The growth of medical tourism in Thailand is related to the low cost of skilled labor and supply of hospital beds, which also make Thailand an appealing location for clinical trials. Thailand is actively courting clinical studies with lower requirements for first-in-human studies than other Asian countries such as China and India. The government has been successful in luring contract research organizations including ACLIRES International Ltd. (Bangkok, Thailand), which services Thailand, Vietnam, Cambodia, and Peru.

This government funding includes not only tax rebates but incentives to lure business to targeted areas of the country. The government has also set up several CMOs to service the industry including TCELS’ Cell and Gene Production Unit (CPU; Pathumthani, Thailand), and the National Biopharmaceutical Facility in association with King Mongkut’s University of Technology Thonburi, which operates a biologic pilot plant facility.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU